These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6107377)

  • 21. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of lithium on hypothalamic-pituitary dopaminergic function.
    Lal S; Nair NP; Guyda H
    Acta Psychiatr Scand; 1978 Jan; 57(1):91-6. PubMed ID: 636903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopaminergic and cholinergic influences on motor behavior in chickens.
    Sanberg PR
    J Comp Psychol; 1983 Mar; 97(1):59-68. PubMed ID: 6872506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition by lithium of dopamine receptors in rat prolactin release.
    Tanimoto K; Maeda K; Chihara K
    Brain Res; 1981 Nov; 223(2):335-42. PubMed ID: 6269703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of apomorphine administration on locomotor activity of control and experimental rats withdrawn from long-term haloperidol treatment.
    Bernardi MM; Palermo-Neto J
    Gen Pharmacol; 1983; 14(5):545-7. PubMed ID: 6685669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.
    Creese I; Burt DR; Snyder SH
    Science; 1977 Aug; 197(4303):596-8. PubMed ID: 877576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presynaptic dopamine receptors in striatal nerve endings: absence of haloperidol-induced supersensitivity.
    Raiteri M; Cerrito F; Casazza G; Levi G
    Adv Biochem Psychopharmacol; 1980; 24():37-43. PubMed ID: 7405669
    [No Abstract]   [Full Text] [Related]  

  • 29. Lithium inhibition of norepinephrine and dopamine receptors.
    Flemenbaum A
    Biol Psychiatry; 1977 Aug; 12(4):563-72. PubMed ID: 560884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of lithium on biochemical manifestations of striatal dopamine target cell supersensitivity induced by prolonged haloperidol treatment.
    Le Douarin C; Oblin A; Fage D; Scatton B
    Eur J Pharmacol; 1983 Sep; 93(1-2):55-62. PubMed ID: 6628547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of neuroleptic-induced dopamine receptor supersensitivity by cyclo (Leu-Gly).
    Bhargava HN; Ritzmann RF
    Pharmacol Biochem Behav; 1980 Nov; 13(5):633-6. PubMed ID: 7443732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of early postnatal treatment with haloperidol on the effects induced by small and large doses of apomorphine on locomotion of adult rats.
    Cuomo V; Cattabeni F; Racagni G
    Neuropharmacology; 1983 Sep; 22(9):1137-9. PubMed ID: 6633823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of dopaminergic mesolimbic receptor supersensitivity by haloperidol.
    Davis KL; Hollister LE; Fritz WC
    Life Sci; 1978 Oct; 23(15):1543-8. PubMed ID: 723433
    [No Abstract]   [Full Text] [Related]  

  • 34. Diltiazem suppresses apomorphine-induced fighting and pro-aggressive effect of withdrawal from chronic ethanol or haloperidol in rats.
    Pucilowski O; Kostowski W
    Neurosci Lett; 1988 Oct; 93(1):96-100. PubMed ID: 3211374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term changes in the sensitivity of pre-and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies.
    Martres MP; Costentin J; Baudry M; Marcais H; Protais P; Schwartz JC
    Brain Res; 1977 Nov; 136(2):319-37. PubMed ID: 922486
    [No Abstract]   [Full Text] [Related]  

  • 36. Lithium in combination with haloperidol or thyrotropin-releasing hormone induces jumping in mice.
    Ushijima I; Yamada K; Furukawa T
    Psychopharmacology (Berl); 1982; 76(2):136-8. PubMed ID: 6805023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mode of action of lithium: some biological considerations.
    Bunney WE; Pert A; Rosenblatt J; Pert CB; Gallaper D
    Arch Gen Psychiatry; 1979 Jul; 36(8 Spec No):898-901. PubMed ID: 222227
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of lithium on chronic haloperidol enhanced apomorphine aggression in rats.
    Allikmets LH; Stanley M; Gershon S
    Life Sci; 1979 Jul; 25(2):165-70. PubMed ID: 573834
    [No Abstract]   [Full Text] [Related]  

  • 39. Lithium effects on estrogen-induced dopaminergic supersensitivity in rats.
    Dorce VA; Palermo-Neto J
    Brain Res Bull; 1992 Aug; 29(2):239-41. PubMed ID: 1525677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blink rates and receptor supersensitivity.
    Karson CN; Staub RA; Kleinman JE; Wyatt RJ
    Neuropharmacology; 1981 Jan; 20(1):91-3. PubMed ID: 7219685
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.